{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:42:46Z","timestamp":1791841366539,"version":"4.3.4"},"update-to":[{"DOI":"10.1016\/j.obpill.2026.100268","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}},{"DOI":"10.1016\/j.obpill.2025.100181","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"reference-count":291,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019689","name":"Suomen Kardiologinen Seura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01 HL115189"],"award-info":[{"award-number":["2R01 HL115189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK04056"],"award-info":[{"award-number":["P30 DK04056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UE5 DK137285"],"award-info":[{"award-number":["UE5 DK137285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24 DK132733"],"award-info":[{"award-number":["U24 DK132733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.obpill.2026.100269","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:17:44Z","timestamp":1778300264000},"page":"100269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society"],"prefix":"10.1016","volume":"18","author":[{"given":"Dariush","family":"Mozaffarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M","family":"Apovian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shagun","family":"Bindlish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Scott","family":"Butsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Gianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasdeep","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Sanndhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Cody","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamacardio.2024.4657","article-title":"Semaglutide eligibility across all current indications for US adults","volume":"10","author":"Shi","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.obpill.2026.100269_bib2","series-title":"KFF Health Tracking Poll May 2024: The public\u2019s use and views of GLP-1 drugs","author":"Montero","year":"2021"},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.2024.2252","article-title":"GLP-1 agonists for obesity\u2014a new recipe for success?","volume":"331","author":"Mozaffarian","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2026.100269_bib4","series-title":"Weight change with semaglutide","author":"Little","year":"2023"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.13172","article-title":"GLP-1 receptor agonist discontinuation among patients with obesity and\/or type 2 diabetes","volume":"7","author":"Do","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2026.100269_bib6","series-title":"Real-world analysis of glucagon-like peptide-1 (GLP-1) agonist obesity treatment year-two clinical and cost outcomes, Prime Therapeutics","author":"Gleason","year":"2024"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib7","first-page":"860","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamainternmed.2024.2525","article-title":"Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity","volume":"184","author":"Rodriguez","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.obpill.2026.100269_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/DMSO.S141235","article-title":"Reasons for discontinuation of GLP-1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes","volume":"10","author":"Sikirica","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.obpill.2026.100269_bib10","series-title":"Saxenda. Liraglutide injection 3 mg","author":"Nordisk","year":"2024"},{"key":"10.1016\/j.obpill.2026.100269_bib11","series-title":"Wegovy. Semaglutide injection 2.4 mg","author":"Nordisk","year":"2024"},{"key":"10.1016\/j.obpill.2026.100269_bib12","series-title":"Zepbound. Tirzepatide injection, solution","year":"2024"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.obpill.2026.100269_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.obpill.2026.100269_bib16","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.obpill.2026.100269_bib19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"10.1016\/j.obpill.2026.100269_bib21","article-title":"SAT660 Predictors of achieving body weight reduction \u226520% with tirzepatide in people with overweight or obesity in SURMOUNT-1","volume":"7","author":"Srinath","year":"2023","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib22","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.jacl.2023.10.011","article-title":"Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance","volume":"18","author":"Bays","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"10454","key":"10.1016\/j.obpill.2026.100269_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"10456","key":"10.1016\/j.obpill.2026.100269_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib26","first-page":"381","article-title":"Semaglutide, obesity-related heart failure, and type 2 diabetes","volume":"391","author":"Kosiborod","year":"2024","journal-title":"Reply, N Engl J Med"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.obpill.2026.100269_bib28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-8587(24)00182-7","article-title":"STEP 10 Group, Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial","volume":"12","author":"McGowan","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.obpill.2026.100269_bib30","series-title":"Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight","year":"2024"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.obpill.2026.100269_bib32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2026.100269_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.obpill.2026.100269_bib35","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early Parkinson\u2019s disease","volume":"390","author":"Meissner Wassilios","year":"2024","journal-title":"N Engl J Med"},{"issue":"S6","key":"10.1016\/j.obpill.2026.100269_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/alz.089799","article-title":"Evaluation of novel GLP-1 analogue in the treatment of Alzheimer\u2019s disease","volume":"20","author":"Edison","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"16_suppl","key":"10.1016\/j.obpill.2026.100269_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.10607","article-title":"Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer","volume":"42","author":"Shen","year":"2024","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03007995.2016.1251892","article-title":"Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects","volume":"33","author":"Bays","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"24","key":"10.1016\/j.obpill.2026.100269_bib39","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Martinez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2026.100269_bib41","series-title":"Wegovy (semaglutide) injection, for subcutaneous use","author":"Nordisk","year":"2023"},{"key":"10.1016\/j.obpill.2026.100269_bib42","series-title":"Zepbound. Tirzepatide injection, solution","year":"2023"},{"issue":"3\u20134","key":"10.1016\/j.obpill.2026.100269_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.obpill.2026.100269_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajem.2024.01.010","article-title":"GLP-1 agonists: a review for emergency clinicians","volume":"78","author":"Long","year":"2024","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/dia.2014.0188","article-title":"Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"17","author":"Sun","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.obpill.2026.100269_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102427","article-title":"Adverse drug reactions of GLP-1 agonists: a systematic review of case reports","volume":"16","author":"Shetty","year":"2022","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/13543784.2016.1221925","article-title":"Investigational glucagon-like peptide-1 agonists for the treatment of obesity","volume":"25","author":"Tomlinson","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc23-1791","article-title":"Occurrence of gastrointestinal adverse events upon GLP-1 receptor agonist initiation with concomitant metformin use: a post hoc analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6","volume":"47","author":"Klein","year":"2024","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib51","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1172\/JCI78371","article-title":"Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight","volume":"124","author":"Baggio","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.obpill.2026.100269_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2024.6058","article-title":"Ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide","author":"Katz","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.obpill.2026.100269_bib54","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jamainternmed.2024.4346","article-title":"Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials","volume":"184","author":"Wadden","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.obpill.2026.100269_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080679","article-title":"Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study","volume":"388","author":"Shapiro","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.obpill.2026.100269_bib56","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100269_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nut.2017.01.012","article-title":"The excessive caloric intake and micronutrient deficiencies related to obesity after a long-term interdisciplinary therapy","volume":"38","author":"Poli","year":"2017","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib58","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/oby.24067","article-title":"Nutritional considerations with antiobesity medications","volume":"32","author":"Almandoz","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2026.100269_bib59","series-title":"Krause and Mahan's food and the nutrition care process","author":"Raymond","year":"2022"},{"key":"10.1016\/j.obpill.2026.100269_bib60","series-title":"Scientific Report of the 2025 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Health and Human Services and Secretary of Agriculture","year":"2024"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000519503","article-title":"Malnutrition in obesity: is it possible?","volume":"15","author":"Kobylinska","year":"2022","journal-title":"Obes Facts"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"issue":"Suppl 4","key":"10.1016\/j.obpill.2026.100269_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/oby.23910","article-title":"Proportion of caloric restriction-induced weight loss as skeletal muscle","volume":"32","author":"Heymsfield","year":"2024","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13370","article-title":"The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Nuijten","year":"2022","journal-title":"Obes Rev"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.ijo.0803483","article-title":"Changes in fat-free mass during significant weight loss: a systematic review","volume":"31","author":"Chaston","year":"2007","journal-title":"Int J Obes (Lond)."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040423","article-title":"Resistance training prevents muscle loss induced by caloric restriction in obese elderly individuals: a systematic review and meta-analysis","volume":"10","author":"Sardeli","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/nutrit\/nuv065","article-title":"Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis","volume":"74","author":"Kim","year":"2016","journal-title":"Nutr Rev"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib69","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.3390\/nu7085311","article-title":"Protein requirements and recommendations for older people: a review","volume":"7","author":"Nowson","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100269_bib70","article-title":"Epidemiology of sarcopenia: Prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib71","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/jn\/136.6.1453","article-title":"Bone, body weight, and weight reduction: what are the concerns?","volume":"136","author":"Shapses","year":"2006","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MED.0000000000000087","article-title":"Weight loss and bone mineral density","volume":"21","author":"Hunter","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10278","key":"10.1016\/j.obpill.2026.100269_bib73","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib74","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2026.100269_bib75","article-title":"FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize","year":"2024","journal-title":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.obpill.2026.100269_bib78","author":"O'Neill"},{"key":"10.1016\/j.obpill.2026.100269_bib79","first-page":"SP781","article-title":"Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden","volume":"30","author":"Klein","year":"2024","journal-title":"Population Health, Equity & Outcomes"},{"key":"10.1016\/j.obpill.2026.100269_bib80","series-title":"HHS Announces 15 Additional Drugs Selected for Medicare Drug Price Negotiations in Continued Effort to Lower Prescription Drug Costs for Seniors","year":"2025"},{"key":"10.1016\/j.obpill.2026.100269_bib81","author":"Landi"},{"key":"10.1016\/j.obpill.2026.100269_bib82","series-title":"Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year","year":"2023"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib83","first-page":"569","article-title":"Medications for obesity management: effectiveness and value","volume":"29","author":"Atlas","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib84","article-title":"Balancing innovation and affordability in anti-obesity medications: the role of an alternative weight-maintenance program","volume":"2","author":"Kim","year":"2024","journal-title":"Health Aff Sch"},{"key":"10.1016\/j.obpill.2026.100269_bib85","series-title":"Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation","year":"2012"},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib86","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s42255-023-00782-2","article-title":"Total daily energy expenditure has declined over the past three decades due to declining basal expenditure, not reduced activity expenditure","volume":"5","author":"Speakman","year":"2023","journal-title":"Nature Metabolism"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib87","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/ajcn\/nqac075","article-title":"Perspective: Obesity-an unexplained epidemic","volume":"115","author":"Mozaffarian","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib88","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1152\/ajpendo.00094.2021","article-title":"Acute carbohydrate overfeeding: a redox model of insulin action and its impact on metabolic dysfunction in humans","volume":"321","author":"Istfan","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.obpill.2026.100269_bib89","article-title":"2024 Obesity Algorithm\u00ae E-book","author":"Tondt","year":"2024","journal-title":"Obes. Med. Assoc."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib90","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/oby.22444","article-title":"Effect of obesogenic medications on weight-loss outcomes in a behavioral weight-management program","volume":"27","author":"Desalermos","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1037\/amp0000517","article-title":"Lifestyle modification approaches for the treatment of obesity in adults","volume":"75","author":"Wadden","year":"2020","journal-title":"Am. Psychol."},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib92","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jada.2007.07.017","article-title":"Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up","volume":"107","author":"Franz","year":"2007","journal-title":"J. Am. Diet. Assoc."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/oby.20662","article-title":"Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study","volume":"22","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"25 Suppl 2","key":"10.1016\/j.obpill.2026.100269_bib94","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.obpill.2026.100269_bib95","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.obpill.2026.100269_bib96","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2020.21749","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib97","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"31","key":"10.1016\/j.obpill.2026.100269_bib98","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib99","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib100","series-title":"Behavioral counseling interventions","article-title":"Final recommendation statement. Healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors","year":"2020"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib101","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa0804748","article-title":"Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates","volume":"360","author":"Sacks","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib102","unstructured":"National Institutes of Health. Nutrient Recommendations: Dietary Reference Intakes (DRI). National Institutes of Health."},{"key":"10.1016\/j.obpill.2026.100269_bib103","article-title":"Anti-obesity medications and investigational agents: an Obesity Medicine Association (OMA) clinical practice statement (CPS) 2022","volume":"2","author":"Bays","year":"2022","journal-title":"Obes. Pillars"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MLR.0000000000001450","article-title":"Measuring primary care exam length using electronic health record data","volume":"59","author":"Neprash","year":"2021","journal-title":"Med. Care"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s11606-020-05744-y","article-title":"Barriers and facilitators to real-world implementation of the Diabetes Prevention Program in large healthcare systems: Lifestyle coach perspectives","volume":"35","author":"Halley","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib106","article-title":"Facilitators and barriers to implementing the Diabetes Prevention Program in rural church settings: a qualitative study using the Consolidated Framework for Implementation Research","author":"Rawal","year":"2024","journal-title":"J. Rural Health"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib110","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/oby.22594","article-title":"A protocol to deliver intensive behavioral therapy (IBT) for obesity in primary care settings: The MODEL-IBT program","volume":"27","author":"Wadden","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib111","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjmed.2014.04.003","article-title":"A deficiency of nutrition education in medical training","volume":"127","author":"Devries","year":"2014","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib112","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1559827618809934","article-title":"Physicians' dietary knowledge, attitudes, and counseling practices: the experience of a single health care center at changing the landscape for dietary education","volume":"13","author":"Harkin","year":"2019","journal-title":"Am. J. Lifestyle Med."},{"issue":"11","key":"10.1016\/j.obpill.2026.100269_bib113","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.amjmed.2017.04.043","article-title":"A deficiency of nutrition education and practice in cardiology","volume":"130","author":"Devries","year":"2017","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12909-020-1925-z","article-title":"Low priority of obesity education leads to lack of medical students' preparedness to effectively treat patients with obesity: results from the U.S. medical school obesity education curriculum benchmark study","volume":"20","author":"Butsch","year":"2020","journal-title":"BMC Med. Educ."},{"issue":"23","key":"10.1016\/j.obpill.2026.100269_bib115","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1161\/CIR.0000000000000563","article-title":"Medical nutrition education, training, and competencies to advance guideline-based diet counseling by physicians: a science advisory from the American Heart Association","volume":"137","author":"Aspry","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib116","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35425","article-title":"Proposed nutrition competencies for medical students and physician trainees: a consensus statement","volume":"7","author":"Eisenberg","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib117","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajcnut.2024.06.023","article-title":"Nutrition education in medical training: it's always been a matter of trust","volume":"120","author":"Devries","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.obpill.2026.100269_bib118","series-title":"117th Congress","first-page":"2021","year":"2021"},{"key":"10.1016\/j.obpill.2026.100269_bib119","article-title":"Role of glucagon-like peptide-1 (GLP-1) receptor agonists in hypoglycemia","volume":"14","author":"Ja'arah","year":"2021","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3109\/0886022X.2012.723777","article-title":"Renal stone disease and obesity: what is important for urologists and nephrologists?","volume":"34","author":"Ahmed","year":"2012","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib121","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semnephrol.2008.01.009","article-title":"Nephrolithiasis after bariatric surgery for obesity","volume":"28","author":"Lieske","year":"2008","journal-title":"Semin. Nephrol."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib122","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ajh.2007.62","article-title":"The association of nephrolithiasis with hypertension and obesity: a review","volume":"21","author":"Obligado","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.obpill.2026.100269_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1032199","article-title":"Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib124","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0895-4356(90)90099-B","article-title":"Validation of a self-administered diet history questionnaire using multiple diet records","volume":"43","author":"Block","year":"1990","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025064","article-title":"Validation of a brief dietary questionnaire for use in clinical practice: Mini-EAT (Eating Assessment Tool)","volume":"12","author":"Lara-Breitinger","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/nu13051536","article-title":"Association between dietary inflammatory index, dietary patterns, plant-based dietary index and the risk of obesity","volume":"13","author":"Wang","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib127","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmjnph-2020-000134","article-title":"Relative validity and reliability of a diet risk score (DRS) for clinical practice","volume":"3","author":"Johnston","year":"2020","journal-title":"BMJ Nutr. Prev. Health"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib128","first-page":"569","article-title":"Nutrient deficiencies secondary to bariatric surgery","volume":"7","author":"Alvarez-Leite","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.obpill.2026.100269_bib129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2024.08.179","article-title":"Higher caloric ratio of carbohydrate intake associated with increased risk of depression: a cross-sectional analysis of NHANES data from 2005 to 2020","volume":"366","author":"Tan","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib130","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0405","article-title":"The emerging role of glucagon-like peptide 1 in binge eating","volume":"262","author":"Balantekin","year":"2024","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib131","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/eat.24109","article-title":"Use of glucagon-like peptide-1 receptor agonists in eating disorder populations","volume":"57","author":"Bartel","year":"2024","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.obpill.2026.100269_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110303","article-title":"The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review","volume":"110","author":"Guerrero-Hreins","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.obpill.2026.100269_bib134","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jad.2024.10.062","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: a replication study using reports to the World Health Organization pharmacovigilance database (VigiBase\u00ae)","volume":"369","author":"McIntyre","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/87551225221110850","article-title":"Effect of antidepressants on glucagon-like peptide-1 receptor agonist-related weight loss","volume":"38","author":"Durell","year":"2022","journal-title":"J. Pharm. Technol."},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib136","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.amepre.2021.01.012","article-title":"Validity of the exercise vital sign tool to assess physical activity","volume":"60","author":"Kuntz","year":"2021","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib137","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0163278720928500","article-title":"Assessment of physical activity in adults: a review of validated questionnaires from a nutritionist's point of view","volume":"43","author":"Bacelis-Rivero","year":"2020","journal-title":"Eval. Health Prof."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib138","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/15598276231214712","article-title":"Content and face validation of the lifestyle medicine assessment","volume":"18","author":"Bonnet","year":"2024","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.obpill.2026.100269_bib139","doi-asserted-by":"crossref","DOI":"10.1177\/15598276241280207","article-title":"Development and psychometric evaluation of the lifestyle medicine health behavior scale","author":"Pangalangan","year":"2024","journal-title":"Am. J. Lifestyle Med."},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib140","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s11606-018-4531-6","article-title":"Acute kidney injury due to diarrheal illness requiring hospitalization: data from the National Inpatient Sample","volume":"33","author":"Bradshaw","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib141","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.2147\/DMSO.S494919","article-title":"Dietary recommendations for the management of gastrointestinal symptoms in patients treated with GLP-1 receptor agonist","volume":"17","author":"Gentinetta","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.obpill.2026.100269_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.793004","article-title":"GLP-1 suppresses feeding behaviors and modulates neuronal electrophysiological properties in multiple brain regions","volume":"14","author":"Chen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.obpill.2026.100269_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114622","article-title":"Glucagon-like peptide 1 agonist and effects on reward behaviour: a systematic review","volume":"283","author":"Badulescu","year":"2024","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.obpill.2026.100269_bib144","article-title":"Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities","author":"Bettadapura","year":"2024","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI88878","article-title":"Hypothalamic inflammation in obesity and metabolic disease","volume":"127","author":"Jais","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.obpill.2026.100269_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179583","article-title":"Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases","volume":"23","author":"Diz-Chaves","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib147","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/oby.23673","article-title":"Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight\/obesity: STEP 5, Obesity","volume":"31","author":"Wharton","year":"2023","journal-title":"Silver Spring, Md)"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib148","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib149","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41366-019-0348-6","article-title":"Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial","volume":"44","author":"Tronieri","year":"2020","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib150","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib151","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.14255","article-title":"Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes","volume":"23","author":"Gibbons","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.obpill.2026.100269_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2022.113967","article-title":"Short-term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity","volume":"257","author":"Nicolau","year":"2022","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib153","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10550887.2024.2315365","article-title":"Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study","volume":"42","author":"Nicolau","year":"2024","journal-title":"J. Addict. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.obpill.2026.100269_bib154","article-title":"128-OR: The effect of tirzepatide during weight loss on food intake, appetite, food preference, and food craving in people with obesity","volume":"72","author":"Martin","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.obpill.2026.100269_bib155","article-title":"Ozempic could crush the junk food industry. But it is fighting back","author":"Weber","year":"2024","journal-title":"The New York Times Magazine"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib156","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/dom.15113","article-title":"Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: a randomized trial in adults with obesity and prediabetes, Diabetes","volume":"25","author":"Silver","year":"2023","journal-title":"Obes. Metab."},{"key":"10.1016\/j.obpill.2026.100269_bib157","author":"Reynolds"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib158","first-page":"1718","article-title":"Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition? Diabetes","volume":"47","author":"Locatelli","year":"2024","journal-title":"Care"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib159","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.clnu.2022.07.041","article-title":"Advances in muscle health and nutrition: a toolkit for healthcare professionals","volume":"41","author":"Prado","year":"2022","journal-title":"Clin. Nutr."},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/07853890.2018.1511918","article-title":"Implications of low muscle mass across the continuum of care: a narrative review","volume":"50","author":"Prado","year":"2018","journal-title":"Ann. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib161","series-title":"Dietary Reference Intakes: The Essential Guide to Nutrient Requirements","year":"2006"},{"key":"10.1016\/j.obpill.2026.100269_bib162","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clnesp.2022.01.014","article-title":"Calculation of protein requirements; a comparison of calculations based on bodyweight and fat free mass","volume":"48","author":"Dekker","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib163","doi-asserted-by":"crossref","first-page":"1320S","DOI":"10.3945\/ajcn.114.084038","article-title":"The role of protein in weight loss and maintenance","volume":"101","author":"Leidy","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib164","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13668-024-00548-6","article-title":"Nutritional considerations during major weight loss therapy: focus on optimal protein and a low-carbohydrate dietary pattern","volume":"13","author":"Volek","year":"2024","journal-title":"Curr. Nutr. Rep."},{"issue":"14","key":"10.1016\/j.obpill.2026.100269_bib165","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1056\/NEJMra2214275","article-title":"Guidance on energy and macronutrients across the life span","volume":"390","author":"Heymsfield","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.obpill.2026.100269_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2024.104486","article-title":"Sculpting success: the importance of diet and physical activity to support skeletal muscle health during weight loss with new generation anti-obesity medications","volume":"8","author":"Grosicki","year":"2024","journal-title":"Curr. Dev. Nutr."},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib167","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124819","article-title":"A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans","volume":"4","author":"Charidemou","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib168","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.advnut.2023.04.001","article-title":"Nutrition and exercise interventions to improve body composition for persons with overweight or obesity near retirement age: a systematic review and network meta-analysis of randomized controlled trials","volume":"14","author":"Eglseer","year":"2023","journal-title":"Adv. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.obpill.2026.100269_bib169","article-title":"14-PUB: The effect of structured intensive lifestyle intervention on muscle mass in patients with type 2 diabetes receiving GLP-1 receptor agonists","volume":"73","author":"Al-Badri","year":"2024","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib170","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","article-title":"Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial","volume":"22","author":"Sandsdal","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.obpill.2026.100269_bib172","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/db22-0745","article-title":"Liraglutide and exercise synergistically attenuate vascular inflammation and enhance metabolic insulin action in early diet-induced obesity","volume":"72","author":"Liu","year":"2023","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib173","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/oby.23930","article-title":"Physical activity in the new era of antiobesity medications, Obesity","volume":"32","author":"Jakicic","year":"2024","journal-title":"Silver Spring)"},{"key":"10.1016\/j.obpill.2026.100269_bib174","doi-asserted-by":"crossref","first-page":"33","DOI":"10.53941\/tmep.v1i1.33","article-title":"Exercise, pharmaceutical therapies and type 2 diabetes: Looking beyond glycemic control to whole body health and function","author":"Yates","year":"2021","journal-title":"Transl. Med. Exerc. Prescr."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3803\/EnM.2019.34.3.247","article-title":"A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans, Endocrinol","volume":"34","author":"Sargeant","year":"2019","journal-title":"Metab. (Seoul)"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib176","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13679-024-00593-w","article-title":"Updates on methods for body composition analysis: implications for clinical practice","volume":"14","author":"Thomas","year":"2025","journal-title":"Curr. Obes. Rep."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib177","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41746-022-00628-3","article-title":"Smartphone camera-based assessment of adiposity: a validation study","volume":"5","author":"Majmudar","year":"2022","journal-title":"NPJ Digit. Med."},{"issue":"14","key":"10.1016\/j.obpill.2026.100269_bib178","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.obpill.2026.100269_bib179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"Reviewers of the AACEOCPG, American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"issue":"20","key":"10.1016\/j.obpill.2026.100269_bib180","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2026.100269_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2023.100070","article-title":"Comprehensive care for patients with obesity: an Obesity Medicine Association position statement","volume":"7","author":"Fitch","year":"2023","journal-title":"Obesity Pillars"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib182","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/15598276221146125","article-title":"The power and connection of the six pillars","volume":"17","author":"Frates","year":"2023","journal-title":"Am. J. Lifestyle Med."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib183","first-page":"402","article-title":"Sleep and obesity","volume":"14","author":"Beccuti","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib184","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr. Obes. Rep."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1009","article-title":"Use and performance of the STOP-Bang questionnaire for obstructive sleep apnea screening across geographic regions: a systematic review and meta-analysis","volume":"4","author":"Pivetta","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.obpill.2026.100269_bib186","first-page":"52","article-title":"The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis, Sleep Med","volume":"25","author":"Mollayeva","year":"2016","journal-title":"Rev."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib187","first-page":"96","article-title":"Body mass index and sleep disturbances: a systematic review and meta-analysis","volume":"32","author":"Amiri","year":"2023","journal-title":"Postep. Psychiatr. Neurol."},{"key":"10.1016\/j.obpill.2026.100269_bib188","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2018.04.042","article-title":"The association between obesity and restless legs syndrome: a systemic review and meta-analysis of observational studies","volume":"235","author":"Lin","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib189","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13679-011-0006-3","article-title":"Effects of chronic social stress on obesity","volume":"1","author":"Scott","year":"2012","journal-title":"Curr. Obes. Rep."},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib190","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/oby.21910","article-title":"Mindfulness-based stress reduction in women with overweight or obesity: a randomized clinical trial, Obesity","volume":"25","author":"Raja-Khan","year":"2017","journal-title":"Silver Spring, Md)"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244847","article-title":"Keeping weight off: mindfulness-based stress reduction alters amygdala functional connectivity during weight loss maintenance in a randomized control trial","volume":"16","author":"Chumachenko","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.obpill.2026.100269_bib192","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.copsyc.2018.12.014","article-title":"Mindfulness and physical disease: a concise review","volume":"28","author":"Greeson","year":"2019","journal-title":"Curr. Opin. Psychol."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib193","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/10615806.2014.994204","article-title":"Assessment of stress and self-efficacy for the NIH Toolbox for Neurological and Behavioral Function","volume":"28","author":"Kupst","year":"2015","journal-title":"Anxiety Stress Coping"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib194","first-page":"613","article-title":"An ultra-brief screening scale for anxiety and depression: the PHQ-4","volume":"50","author":"Kroenke","year":"2009","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0b013e3181ce38e7","article-title":"The treatment of obesity and its co-occurrence with substance use disorders","volume":"4","author":"Vanbuskirk","year":"2010","journal-title":"J. Addict. Med."},{"issue":"Pt B","key":"10.1016\/j.obpill.2026.100269_bib196","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2018.01.013","article-title":"GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence","volume":"136","author":"Jerlhag","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib197","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amepre.2016.07.033","article-title":"Institute of Medicine measures of social and behavioral determinants of health: a feasibility study","volume":"52","author":"Giuse","year":"2017","journal-title":"Am. J. Prev. Med."},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217264","article-title":"Social network structure is predictive of health and wellness","volume":"14","author":"Lin","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib199","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1559827615608788","article-title":"The connection prescription: using the power of social interactions and the deep desire for connectedness to empower health and wellness","volume":"11","author":"Martino","year":"2017","journal-title":"Am. J. Lifestyle Med."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMsa066082","article-title":"The spread of obesity in a large social network over 32 years","volume":"357","author":"Christakis","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib201","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52824","article-title":"Improvement of social isolation and loneliness and excess mortality risk in people with obesity","volume":"7","author":"Zhou","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib202","first-page":"2439","article-title":"The effect of peer support on individuals with overweight and obesity: a meta-analysis, Iran","volume":"50","author":"Chen","year":"2021","journal-title":"J. Public Health"},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2019.4802","article-title":"Comparison of group medical visits combined with intensive weight management vs group medical visits alone for glycemia in patients with type 2 diabetes: a noninferiority randomized clinical trial","volume":"180","author":"Yancy","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib204","article-title":"Opportunities for general internal medicine to promote equity in obesity care","author":"Kane","year":"2024","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib205","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1559827616638018","article-title":"Leveraging time with lifestyle-based group visits","volume":"10","author":"Patel Saxena","year":"2016","journal-title":"Am. J. Lifestyle Med."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1559827620943819","article-title":"Lifestyle medicine shared medical appointments","volume":"15","author":"Lacagnina","year":"2021","journal-title":"Am. J. Lifestyle Med."},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib207","first-page":"780","article-title":"Effectiveness of shared medical appointments targeting the triple aim among patients with overweight, obesity, or diabetes","volume":"116","author":"Trickett","year":"2016","journal-title":"J. Am. Osteopath. Assoc."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12889-022-12833-6","article-title":"A nutrition and lifestyle-focused shared medical appointment in a resource-challenged community setting: a mixed-methods study","volume":"22","author":"Bharmal","year":"2022","journal-title":"BMC Public Health"},{"issue":"13","key":"10.1016\/j.obpill.2026.100269_bib209","doi-asserted-by":"crossref","first-page":"E635","DOI":"10.1503\/cmaj.130053","article-title":"Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis","volume":"185","author":"Housden","year":"2013","journal-title":"Cmaj"},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib210","first-page":"710","article-title":"Shared medical appointments for weight loss: a systematic review, Fam","volume":"39","author":"Walker","year":"2022","journal-title":"Pract"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib211","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/osp4.406","article-title":"Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity","volume":"6","author":"Shibuya","year":"2020","journal-title":"Obes. Sci. Pract."},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib212","first-page":"60","article-title":"Group medical visits for addressing weight and blood pressure in an underserved population","volume":"9","author":"Algotar","year":"2022","journal-title":"Medicines (Basel)"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib213","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/oby.2006.84","article-title":"The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it","volume":"14","author":"Look","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2026.100269_bib214","article-title":"Group medical appointments for intensive lifestyle treatment for obesity in Cleveland Clinic primary care practices","author":"Anita","year":"2024","journal-title":"Patient Cent. Outcomes Res. Inst."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jand.2023.11.013","article-title":"Position of the Academy of Nutrition and Dietetics: medical nutrition therapy behavioral interventions provided by dietitians for adults with overweight or obesity","volume":"124","author":"Raynor","year":"2024","journal-title":"J. Acad. Nutr. Diet."},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib216","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jand.2017.06.364","article-title":"Effectiveness of dietetic consultations in primary health care: a systematic review of randomized controlled trials","volume":"117","author":"Mitchell","year":"2017","journal-title":"J. Acad. Nutr. Diet."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib217","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/healthcare7010020","article-title":"How effective are dietitians in weight management? A systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Williams","year":"2019","journal-title":"Healthcare (Basel)"},{"issue":"10","key":"10.1016\/j.obpill.2026.100269_bib218","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jand.2017.06.361","article-title":"Medical nutrition therapy and weight loss questions for the evidence analysis library prevention of type 2 diabetes project: systematic reviews","volume":"117","author":"Raynor","year":"2017","journal-title":"J. Acad. Nutr. Diet."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib219","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pcd.2019.05.001","article-title":"The health effects of medical nutrition therapy by dietitians in patients with diabetes: a systematic review and meta-analysis","volume":"13","author":"Razaz","year":"2019","journal-title":"Prim. Care Diabetes"},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib220","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jand.2022.11.014","article-title":"Medical nutrition therapy interventions provided by dietitians for adult overweight and obesity management: an Academy of Nutrition and Dietetics evidence-based practice guideline","volume":"123","author":"Morgan-Bathke","year":"2023","journal-title":"J. Acad. Nutr. Diet."},{"issue":"3","key":"10.1016\/j.obpill.2026.100269_bib222","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jand.2024.10.023","article-title":"Incretin-based therapies and lifestyle interventions: the evolving role of registered dietitian nutritionists in obesity care","volume":"125","author":"Gigliotti","year":"2025","journal-title":"J. Acad. Nutr. Diet."},{"key":"10.1016\/j.obpill.2026.100269_bib223","unstructured":"US Congress. United States Code: Social Security Act, U.S.C. \u00a7 1395x: Definitions. From Title 42 -The Public Health and Welfare. Chapter 7-Social Security. Subchapter XVII-Health Insurance for Aged And Disabled. Part E-Miscellaneous Provisions."},{"key":"10.1016\/j.obpill.2026.100269_bib224","article-title":"Proposed rule: Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly","year":"2024","journal-title":"Federal Register, United States Government"},{"key":"10.1016\/j.obpill.2026.100269_bib225","volume":"2023-2024","author":"US Congress","year":"2023"},{"issue":"7","key":"10.1016\/j.obpill.2026.100269_bib226","article-title":"Revolutionizing healthcare: how telemedicine is improving patient outcomes and expanding access to care","volume":"16","author":"Ezeamii","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.obpill.2026.100269_bib227","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3945\/ajcn.116.136333","article-title":"Telehealth methods to deliver dietary interventions in adults with chronic disease: a systematic review and meta-analysis","volume":"104","author":"Kelly","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib228","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/tmj.2014.9981","article-title":"The empirical foundations of telemedicine interventions for chronic disease management","volume":"20","author":"Bashshur","year":"2014","journal-title":"Telemed. e-Health"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib229","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016242","article-title":"Telehealth and patient satisfaction: a systematic review and narrative analysis","volume":"7","author":"Kruse","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib230","doi-asserted-by":"crossref","DOI":"10.2196\/34326","article-title":"Barriers to telemedicine video visits for older adults in independent living facilities: mixed methods cross-sectional needs assessment","volume":"5","author":"Mao","year":"2022","journal-title":"JMIR Aging"},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib231","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2023.12.023","article-title":"\"Food is medicine\" strategies for nutrition security and cardiometabolic health equity: JACC state-of-the-art review","volume":"83","author":"Mozaffarian","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.obpill.2026.100269_bib232","volume":"2023\u20132024","year":"2023"},{"key":"10.1016\/j.obpill.2026.100269_bib233","unstructured":"Centers for Disease Control and Prevention. What is Health Equity? : Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/health-equity\/what-is\/index.html."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib234","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ecl.2023.05.003","article-title":"Equity in obesity review, Endocrinol","volume":"52","author":"Kendrick","year":"2023","journal-title":"Metab. Clin. North Am."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gtc.2023.02.003","article-title":"Disparities in access and quality of obesity care","volume":"52","author":"Washington","year":"2023","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib236","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41591-023-02669-x","article-title":"Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity","volume":"30","author":"Waldrop","year":"2024","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib237","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.obpill.2026.100269_bib238","article-title":"Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes","volume":"34","author":"Rodriguez","year":"2024","journal-title":"Lancet Reg. Health Am"},{"issue":"19","key":"10.1016\/j.obpill.2026.100269_bib239","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025545","article-title":"Racial and ethnic disparities in financial barriers among overweight and obese adults eligible for semaglutide in the United States","volume":"11","author":"Lu","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib240","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.amepre.2024.06.021","article-title":"Ending weight stigma to advance health equity","volume":"67","author":"Pearl","year":"2024","journal-title":"Am. J. Prev. Med."},{"issue":"12","key":"10.1016\/j.obpill.2026.100269_bib241","first-page":"4757","article-title":"A review of racial and ethnic disparities in obesity treatment","volume":"11","author":"Lele","year":"2023","journal-title":"Med. Res. Arch."},{"key":"10.1016\/j.obpill.2026.100269_bib242","unstructured":"Healthy People 2030. Reduce household food insecurity and hunger \u2014 NWS-01 Infographic. [Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services. https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/browseobjectives\/nutrition-and-healthy-eating\/reduce-household-foodinsecurity-and-hunger-nws-01."},{"key":"10.1016\/j.obpill.2026.100269_bib243","unstructured":"Healthy People 2030. Current Population Survey Food Security Supplement (CPS-FSS). In: Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services, ed. https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/data-sourcesand-methods\/data-sources\/current-population-survey-food-securitysupplement-cps-fss."},{"key":"10.1016\/j.obpill.2026.100269_bib244","unstructured":"Healthy People 2030. Reduce household food insecurity and hunger \u2014 NWS-01 Data. In: Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services, ed. https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/browseobjectives\/nutrition-and-healthy-eating\/reduce-household-foodinsecurity-and-hunger-nws-01."},{"key":"10.1016\/j.obpill.2026.100269_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2024.103151","article-title":"Development, implementation, and validation of 2-item nutrition security screener","volume":"8","author":"Craig","year":"2024","journal-title":"Curr. Dev. Nutr."},{"key":"10.1016\/j.obpill.2026.100269_bib247","series-title":"Declaration of Ny\u00e9l\u00e9ni: declaration of the forum for food sovereignty","author":"S\u00e9lingu\u00e9","year":"2007"},{"issue":"9","key":"10.1016\/j.obpill.2026.100269_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2023.101973","article-title":"Elements of successful food sovereignty interventions within Indigenous communities in the United States and Canada: a systematic review","volume":"7","author":"Gutierrez","year":"2023","journal-title":"Curr. Dev. Nutr."},{"issue":"7","key":"10.1016\/j.obpill.2026.100269_bib249","doi-asserted-by":"crossref","DOI":"10.1093\/cdn\/nzab093","article-title":"A scoping review of the use of Indigenous food sovereignty principles for intervention and future directions","volume":"5","author":"Maudrie","year":"2021","journal-title":"Curr. Dev. Nutr."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib250","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jada.2008.12.019","article-title":"Diet-related disparities: understanding the problem and accelerating solutions","volume":"109","author":"Satia","year":"2009","journal-title":"J. Am. Diet. Assoc."},{"issue":"Suppl 2","key":"10.1016\/j.obpill.2026.100269_bib251","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cdn\/nzz054","article-title":"Social determinants of American Indian nutritional health","volume":"3","author":"Warne","year":"2019","journal-title":"Curr. Dev. Nutr."},{"issue":"4","key":"10.1016\/j.obpill.2026.100269_bib252","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cmet.2024.02.001","article-title":"Developing a national nutrition policy strategy to advance cardiometabolic health and health equity","volume":"36","author":"Mozaffarian","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.obpill.2026.100269_bib253","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12937-023-00844-x","article-title":"Patterns and correlates of nutrition knowledge across five countries in the 2018 international food policy study","volume":"22","author":"Bhawra","year":"2023","journal-title":"Nutr. J."},{"key":"10.1016\/j.obpill.2026.100269_bib254","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fphys.2018.00994","article-title":"Are nutrition-related knowledge and attitudes reflected in lifestyle and health among elderly people? A study across five European countries","volume":"9","author":"Jeruszka-Bielak","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.obpill.2026.100269_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112354","article-title":"Influence of culinary skills on ultraprocessed food consumption and Mediterranean diet adherence: an integrative review","volume":"121","author":"Watanabe","year":"2024","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib256","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.foodqual.2012.04.007","article-title":"Socio-demographic and attitudinal determinants of nutrition knowledge of food shoppers in six European countries","volume":"26","author":"Grunert","year":"2012","journal-title":"Food Qual. Prefer."},{"issue":"13","key":"10.1016\/j.obpill.2026.100269_bib257","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8807","article-title":"How distorted food prices discourage a healthy diet","volume":"8","author":"Pancrazi","year":"2022","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.obpill.2026.100269_bib258","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1016\/S2468-2667(19)30105-7","article-title":"The effect of food price changes on consumer purchases: a randomised experiment","volume":"4","author":"Waterlander","year":"2019","journal-title":"Lancet Public Health"},{"issue":"22","key":"10.1016\/j.obpill.2026.100269_bib259","doi-asserted-by":"crossref","DOI":"10.3390\/nu15224708","article-title":"Nutrition and food literacy: framing the challenges to health communication","volume":"15","author":"Silva","year":"2023","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.obpill.2026.100269_bib260","doi-asserted-by":"crossref","DOI":"10.3390\/nu16162809","article-title":"Nutrition and physical activity education in medical school: a narrative review","volume":"16","author":"Sousa","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100269_bib261","series-title":"Doctoring our diet II: nutrition education for physicians is overdue, Food Law and Policy Clinic, Harvard Law School","author":"Findley","year":"2024"},{"key":"10.1016\/j.obpill.2026.100269_bib262","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40795-019-0293-8","article-title":"The effect of culinary interventions (cooking classes) on dietary intake and behavioral change: a systematic review and evidence map","volume":"5","author":"Hasan","year":"2019","journal-title":"BMC Nutr."},{"issue":"2","key":"10.1016\/j.obpill.2026.100269_bib263","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/jhn.12944","article-title":"Culinary medicine and culinary nutrition education for individuals with the capacity to influence health-related behavior change: a scoping review","volume":"35","author":"Asher","year":"2022","journal-title":"J. Hum. Nutr. Diet."},{"issue":"13","key":"10.1016\/j.obpill.2026.100269_bib264","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132859","article-title":"Perspective: teaching kitchens: conceptual origins, applications and potential for impact within food is medicine research","volume":"15","author":"Eisenberg","year":"2023","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.obpill.2026.100269_bib265","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17238932","article-title":"Outcomes of culturally tailored dietary intervention in the North African and Bangladeshi diabetic patients in Italy","volume":"17","author":"Piombo","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"10.1016\/j.obpill.2026.100269_bib266","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0145721710376328","article-title":"Translating current dietary guidelines into a culturally tailored nutrition education program for Korean American immigrants with type 2 diabetes","volume":"36","author":"Song","year":"2010","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.obpill.2026.100269_bib267","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s12889-016-3370-9","article-title":"A community-based lifestyle and weight loss intervention promoting a Mediterranean-style diet pattern evaluated in the stroke belt of North Carolina: the Heart Healthy Lenoir Project","volume":"16","author":"Keyserling","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.obpill.2026.100269_bib268","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.obpill.2026.100269_bib269","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11154-013-9261-9","article-title":"Brain regulation of energy balance and body weight","volume":"14","author":"Rui","year":"2013","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.obpill.2026.100269_bib270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrn3745","article-title":"Neurobiology of food intake in health and disease","volume":"15","author":"Morton","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.obpill.2026.100269_bib271","article-title":"Definition and diagnostic criteria of clinical obesity, Lancet. Diabetes","author":"Rubino","year":"2025","journal-title":"Endocrinol"},{"key":"10.1016\/j.obpill.2026.100269_bib272","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajcnut.2024.01.007","article-title":"Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions \u2013 a narrative review","volume":"119","author":"Huber","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.obpill.2026.100269_bib273","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2018.07.061","article-title":"Genetic variants in SGLT1, glucose tolerance, and cardiometabolic risk","volume":"72","author":"Seidelmann","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.obpill.2026.100269_bib274","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/molecules26030703","article-title":"The emerging role of polyphenols in the management of type 2 diabetes","volume":"26","author":"Wang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.obpill.2026.100269_bib275","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biochi.2019.08.013","article-title":"Curcumin induces secretion of glucagon-like peptide-1 through an oxidation-dependent mechanism","volume":"165","author":"Alli-Oluwafuyi","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.obpill.2026.100269_bib276","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ajhp\/zxz284","article-title":"A systematic overview of systematic reviews evaluating medication adherence interventions","volume":"77","author":"Anderson","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.obpill.2026.100269_bib279","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.2024.22284","article-title":"Discontinuation of glucagon-like peptide-1 receptor agonists","volume":"333","author":"Khan","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2026.100269_bib280","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13003","article-title":"Successful weight loss maintenance: a systematic review of weight control registries","volume":"21","author":"Paixao","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.obpill.2026.100269_bib281","first-page":"467","article-title":"Special report: potential strategies for addressing GLP-1 and dual GLP-1\/GIP receptor agonist shortages, Clin","volume":"41","author":"Whitley","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.obpill.2026.100269_bib282","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.33000","article-title":"Cost-related prescription drug rationing by adults with obesity","volume":"7","author":"Chen","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.obpill.2026.100269_bib283","article-title":"Ozempic (glucagon-like peptide 1 receptor agonist) in social media posts: unveiling user perspectives through Reddit topic modeling","volume":"4","author":"Fong","year":"2024","journal-title":"Emerg. Trends. Drugs. Addict. Health."},{"key":"10.1016\/j.obpill.2026.100269_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101182","article-title":"Trends in glucagon-like peptide-1 receptor agonist social media posts using artificial intelligence","volume":"3","author":"Javaid","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.obpill.2026.100269_bib285","article-title":"FDA\u2019s Concerns with unapproved GLP-1 drugs used for weight loss","year":"2024","journal-title":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.obpill.2026.100269_bib286","first-page":"NP279","article-title":"Practice patterns and perspectives of the off-label use of GLP-1 agonists for cosmetic weight loss, Aesthetic","volume":"44","author":"Han","year":"2024","journal-title":"Surg. J."},{"key":"10.1016\/j.obpill.2026.100269_bib287","author":"Cohen"},{"key":"10.1016\/j.obpill.2026.100269_bib288","article-title":"Mounjaro may work better than ozempic for weightloss","author":"Radcliffe","year":"2023","journal-title":"study finds"},{"key":"10.1016\/j.obpill.2026.100269_bib289","author":"Zilstorff"},{"key":"10.1016\/j.obpill.2026.100269_bib290","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.07.006","article-title":"Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials","volume":"131","author":"Meng","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.obpill.2026.100269_bib291","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41387-020-00142-z","article-title":"Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis","volume":"10","author":"Yuan","year":"2020","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.obpill.2026.100269_bib292","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/nu13030967","article-title":"Adherence to ketogenic and Mediterranean study diets in a crossover trial: the Keto-Med randomized trial","volume":"13","author":"Landry","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100269_bib293","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2337\/dc16-0690","article-title":"Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial","volume":"39","author":"Ahren","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2026.100269_bib294","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/dom.13030","article-title":"Severe hypoglycaemia among patients with type 2 diabetes requiring emergency hospital admission: the Hypoglycaemia In Portugal Observational Study-Emergency Room (HIPOS-ER)","volume":"20","author":"Conceicao","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.obpill.2026.100269_bib295","first-page":"588","article-title":"Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial, Diabet","volume":"35","author":"Corley","year":"2018","journal-title":"Med"},{"key":"10.1016\/j.obpill.2026.100269_bib296","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tem.2024.01.007","article-title":"Clinical potential of fasting in type 1 diabetes","volume":"35","author":"Varady","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.obpill.2026.100269_bib297","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7809611","article-title":"Effect of intermittent fasting (18\/6) on energy expenditure, nutritional status, and body composition in healthy adults","volume":"2021","author":"Agagunduz","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.obpill.2026.100269_bib298","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00394-022-02804-3","article-title":"Intermittent fasting and continuous energy restriction result in similar changes in body composition and muscle strength when combined with a 12-week resistance training program","volume":"61","author":"Keenan","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.obpill.2026.100269_bib299","article-title":"Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait","volume":"383","author":"Touvier","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.obpill.2026.100269_bib300","article-title":"Association between ultra-processed food consumption and mortality among U.S. adults: prospective cohort study of the National Health And Nutrition Examination Survey 2003\u20132018","author":"Wang","year":"2024","journal-title":"J. Acad. Nutr. Diet."},{"key":"10.1016\/j.obpill.2026.100269_bib301","article-title":"Ultra-processed foods and cardiovascular disease: analysis of three large US prospective cohorts and a systematic review and meta-analysis of prospective cohort studies","volume":"37","author":"Mendoza","year":"2024","journal-title":"Lancet. Reg. Health Am"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:41:17Z","timestamp":1783100477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":291,"alternative-id":["S2667368126000252"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100269","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100268","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100181","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100269"}}